Homepage
Author:
ImmunoBrain Checkpoint Inc.
Posted Date:
March 19, 2026
ImmunoBrain Presents Clinical Data for First Immune Checkpoint Therapy Approach in Alzheimer’s Disease at AD/PD™ 2026
ImmunoBrain Checkpoint Inc.
March 19, 2026
ImmunoBrain to Present Topline Phase 1b Clinical Data for Immune Checkpoint Treatment in Alzheimer’s Disease at AD/PD™ 2026
ImmunoBrain Checkpoint Inc.
March 12, 2026
